These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9298328)

  • 1. Epstein-Barr virus oncogenesis.
    Knecht H; Berger C; al-Homsi AS; McQuain C; Brousset P
    Crit Rev Oncol Hematol; 1997 Jul; 26(2):117-35. PubMed ID: 9298328
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
    J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epstein-barr virus gene expression in latent infection and B-lymphocyte growth transformation].
    Harada S
    Uirusu; 2002 Jun; 52(1):129-34. PubMed ID: 12227161
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epstein-Barr virus and oncogenesis].
    Sairenji T
    Uirusu; 2002 Dec; 52(2):273-9. PubMed ID: 12685319
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of Epstein-Barr virus-encoded latent membrane protein 1 in nonendemic Burkitt's lymphomas.
    Carbone A; Gloghini A; Zagonel V; Tirelli U
    Blood; 1996 Feb; 87(3):1202-4. PubMed ID: 8562951
    [No Abstract]   [Full Text] [Related]  

  • 6. bcl-2, Epstein-Barr virus-latent membrane protein, EBNA-1, and EBNA-2 staining in posttransplantation lymphoproliferative disorders.
    Chetty R; Biddolph S; Gatter K
    Blood; 1996 Jun; 87(12):5395. PubMed ID: 8652861
    [No Abstract]   [Full Text] [Related]  

  • 7. In situ detection of Epstein-Barr virus in breast cancer.
    Chu JS; Chen CC; Chang KJ
    Cancer Lett; 1998 Feb; 124(1):53-7. PubMed ID: 9500191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Epstein-Barr virus a human oncogene or only an innocent bystander?
    Smith RD
    Hum Pathol; 1997 Dec; 28(12):1333-5. PubMed ID: 9416687
    [No Abstract]   [Full Text] [Related]  

  • 9. A new animal model for Epstein-Barr virus pathogenesis.
    Wang F
    Curr Top Microbiol Immunol; 2001; 258():201-19. PubMed ID: 11443863
    [No Abstract]   [Full Text] [Related]  

  • 10. The Epstein-Barr virus and nasopharyngeal carcinoma.
    Pagano JS
    Cancer; 1994 Nov; 74(9):2397-8. PubMed ID: 7922991
    [No Abstract]   [Full Text] [Related]  

  • 11. Deregulation of the cell cycle by the Epstein-Barr virus.
    O'Nions J; Allday MJ
    Adv Cancer Res; 2004; 92():119-86. PubMed ID: 15530559
    [No Abstract]   [Full Text] [Related]  

  • 12. Epstein-Barr virus immortalization and latency.
    Rowe DT
    Front Biosci; 1999 Mar; 4():D346-71. PubMed ID: 10077545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus and the B cell: that's all it takes.
    Thorley-Lawson DA; Miyashita EM; Khan G
    Trends Microbiol; 1996 May; 4(5):204-8. PubMed ID: 8727601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers.
    Fischer N; Kopper B; Graf N; Schlehofer JR; Grässer FA; Mueller-Lantzsch N
    Virus Res; 1999 Mar; 60(1):41-54. PubMed ID: 10225273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The polymorphic element of the Epstein-Barr virus EBNA-3C gene: a preliminary characteristic and the use for distinguishing between mono- and polyclonal infected cells.
    Myandina GI; Imamova LR; Ostrovskaya AV; Samochatova EV; Itkes AV
    Dokl Biochem; 2000; 371(1-6):53-6. PubMed ID: 10853450
    [No Abstract]   [Full Text] [Related]  

  • 16. EBNA2 and c-myc in B cell immortalization by Epstein-Barr virus and in the pathogenesis of Burkitt's lymphoma.
    Zimber-Strobl U; Strobl L; Höfelmayr H; Kempkes B; Staege MS; Laux G; Christoph B; Polack A; Bornkamm GW
    Curr Top Microbiol Immunol; 1999; 246():315-20; discussion 321. PubMed ID: 10396071
    [No Abstract]   [Full Text] [Related]  

  • 17. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epstein-Barr virus encephalitis].
    Fukaya S; Torikai K
    Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):25-8. PubMed ID: 10201126
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of Epstein-Barr virus-infected cells in benign lymphadenopathy of patients seropositive for human immunodeficiency virus.
    Brousset P; Schlaifer D; Roda D; Massip P; Marchou B; Delsol G
    Hum Pathol; 1996 Mar; 27(3):263-8. PubMed ID: 8600041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus in the pathogenesis of Hodgkin's disease.
    Dolcetti R; Boiocchi M
    Biomed Pharmacother; 1998; 52(1):13-25. PubMed ID: 9755791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.